Skip to main content

Advertisement

Log in

Magnetic resonance imaging (MRI) of feet demonstrates subclinical inflammatory joint disease in cutaneous psoriasis patients without clinical arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

We evaluated inflammation at the small joints of feet in psoriasis patients without clinical arthritis (PsO) as against clinically overt psoriatic arthritis (PsA) patients, using a low field magnet extremity MRI (eMRI). Patients with psoriasis recruited from dermatology and rheumatology clinics of a tertiary care institution in southern India were divided into PsO and PsA groups. Demographic and physical examination details were recorded. Consenting patients underwent non-contrast eMRI of the right foot. Two trained readers scored the MRI parameters of inflammation (synovitis, tenosynovitis, osteitis) using a modification of the PsA magnetic resonance imaging score (PsAMRIS). Proportion of patients with any sign of MRI inflammation was noted. Clinical variables were compared with inflammation scores for any association. A total of 83 patients (30 PsA and 53 PsO), with 75% males and mean age of 42.2 ± 11.6 years were included. There was no statistical difference between the median eMRI inflammatory scores in PsA and PsO patients (p = 0.493). Evidence of inflammation was present in 33.9% and 50% patients in the PsO and PsA groups, respectively. Early arthritis for psoriatic patients screening questionnaire (EARP) score of ≥ 3 was significantly associated with imaging features of inflammation in PsO group (p = 0.044). This study corroborates a high proportion of subclinical inflammation in small joints of foot in PsO patients, which needs to be reproduced in larger, longitudinal cohorts to predict risk factors for progression to future PsA development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gladman DD (2005) Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis 64(Suppl2):ii14–ii17

    PubMed  PubMed Central  Google Scholar 

  2. Zachariae H (2003) Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol 4:441–447

    Article  PubMed  Google Scholar 

  3. Scarpa R, Oriente P, Pucino A, Torella M, Vignone L, Riccio A et al (1984) Psoriatic arthritis in psoriatic patients. Br J Rheumatol 23:246–250

    Article  CAS  PubMed  Google Scholar 

  4. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arhtritis Rheum 54:2665–2673

    Article  Google Scholar 

  5. Catanoso M, Pipitone N, Salvarani C (2012) Epidemiology of psoriatic arthritis. Reumatismo 64:66–70

    Article  CAS  PubMed  Google Scholar 

  6. Lewinson RT, Vellerand IA, Lowerison MW, Parsons LM, Frolkis AD, Kaplan GG et al (2017) Depression is associated with an increased risk of psoriatic arthritis among patients with psoriasis: a population-based study. J Invest Dermatol 137:828–835

    Article  CAS  PubMed  Google Scholar 

  7. Kavanaugh A, Helliwell P, Ritchlin CT (2016) Psoriatic arthritis and burden of disease: patient perspectives from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Rheumatol Ther 3:91–102

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ogdie A, Schwartzman S, Husni ME (2015) Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol 27:118–126

    Article  PubMed  Google Scholar 

  9. Haroon M, Gallagher P, FitzGerald O (2015) Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 74:1045–1050

    Article  CAS  PubMed  Google Scholar 

  10. Kirkham B, de Vlam K, Li W, Boggs R, Mallbris L, Nab HW et al (2015) Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial. Clin Exp Rheumatol 33:11–19

    PubMed  Google Scholar 

  11. Coates LC, Moverley AR, McParland L, Brown S, Navarro-Coy N, O’Dwyer JL et al (2015) Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open label, randomized controlled trial. Lancet 386:2489–2498

    Article  PubMed  PubMed Central  Google Scholar 

  12. Aydin SZ, Ash ZR, Tinazzi I, Castillo-Gallego C, Kwok C, Wilson C et al (2013) The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. Ann Rheum Dis 72:992–995

    Article  PubMed  Google Scholar 

  13. Mathew AJ, Coates LC, Danda D, Conaghan PC (2017) Psoriatic arthritis: lessons from imaging studies and implications for therapy. Exp Rev Clin Immunol 13:133–142

    Article  CAS  Google Scholar 

  14. Faustini F, Simon D, Oliveira I, Kleyer A, Haschka J, Englbretcht M et al (2016) Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis. Ann Rheum Dis 75:2068–2074

    Article  PubMed  Google Scholar 

  15. Mathew AJ, Panwar J, Bird P, George R, Danda D (2016) Utility of extremity magnetic resonance imaging (eMRI) without contrast enhancement in detecting preclinical psoriatic arthritis (abstract). Arthritis Rheumatol 68 (suppl 10)

  16. Soscia E, Sirignano C, Catalano O, Atteno M, Costa L, Caso F et al (2012) New developments in magnetic resonance imaging of the nail unit. J Rheumatol 89:49–53

    Google Scholar 

  17. Ghanem N, Uhl M, Pache G, Bley T, Walker UA, Langer MMRI (2007) In psoriatic arthritis with hand and foot involvement. Rheumatol Int 27:387–393

    Article  PubMed  Google Scholar 

  18. Erdem CZ, Tekin NS, Sarikaya S, Erdem LO, Gulec SMR (2008) Imaging features of foot involvement in patients with psoriasis. Eur J Radiol 67:521–525

    Article  PubMed  Google Scholar 

  19. Glinatsi D, Bird P, Gandjbakhch F, Mease PJ, Boyesen P, Peterfy CG et al (2015) Validation of the OMERACT psoriatic arthritis magnetic resonance imaging score (PsAMRIS) for the hand and foot in a randomized placebo-controlled trial. J Rheumatol 42:2473–2479

    Article  PubMed  Google Scholar 

  20. Mangnus L, Schoones JW, van der Helm-van Mil AH (2015) What is the prevalence of MRI-detected inflammation and erosions in small joints in the general population? A collation and analysis of published data. RMD Open 1:e000005

    Article  PubMed  PubMed Central  Google Scholar 

  21. Freeston JE, Coates LC, Nam JL, Moverley AR, Hensor EM, Wakefield RJ et al (2014) Is there subclinical synovitis in early psoriatic arthritis? A clinical comparison with gray-scale and power Doppler ultrasound. Arthritis Care Res (Hoboken) 66:432–439

    Article  Google Scholar 

  22. Naredo E, Moller I, de Miguel E, Batlle-Gualda E, Acebes C, Brito E et al (2011) High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study. Rheumatology (Oxford) 50:1838–1848

    Article  Google Scholar 

  23. Mishra S, Kancharla H, Dogra S, Sharma A (2017) Comparison of four validated psoriatic arthritis screening tools in diagnosing psoriatic arthritis in patients with psoriasis (COMPAQ study). Br J Dermatol 176:765–770

    Article  CAS  PubMed  Google Scholar 

  24. Poggenborg RP, Pedersen SJ, Eshed I, Sorensen IJ, Moller JM, Madsen OR et al (2015) Head-to-toe whole-body MRI in psoriatic arthritis, axial spondyloarthritis and healthy subjects: first steps towards global inflammation and damage scores of peripheral and axial joints. Rheumatology (Oxford) 54:1039–1049

    Article  CAS  Google Scholar 

  25. Mathew AJ, Bird P (2015) Utility of in-office extremity magnetic resonance imaging in rheumatology. Indian J Rheumatol 10:140–146

    Article  Google Scholar 

Download references

Acknowledgements

We are grateful to the patients who participated in this research study. We thank Rasu E for his role in performing the MRI scans. This work was presented as a poster at the EULAR 2017 in Madrid, Spain.

Funding

This study is supported by the Asia Pacific League of Associations for Rheumatology (APLAR) Research Grant 2015 and Christian Medical College, Vellore Institutional fluid grant.

Author information

Authors and Affiliations

Authors

Contributions

AM was responsible for planning, execution, patient examination, MRI scoring, preparing the initial manuscript draft and completing manuscript revision. PB was the second scorer for MRI and critically revised the manuscript. AG participated by recruiting patients for this study and critically revising the manuscript. RG helped in design of the study and critically revised the manuscript. DD acted as the supervisor for this study, helping in designing, interpreting data and critically revising the manuscript. All authors have approved the final manuscript.

Corresponding author

Correspondence to Debashish Danda.

Ethics declarations

Disclosures

None.

Ethics approval and registration

Christian Medical College Institution Review Board and Ethics Committee (IRB Min. No 9543 dt 22.07.15, CMC Vellore).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mathew, A.J., Bird, P., Gupta, A. et al. Magnetic resonance imaging (MRI) of feet demonstrates subclinical inflammatory joint disease in cutaneous psoriasis patients without clinical arthritis. Clin Rheumatol 37, 383–388 (2018). https://doi.org/10.1007/s10067-017-3895-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3895-z

Keywords

Navigation